New findings could provide additional insight into the cause of glioblastoma and provide new options for personalized therapeutic treatments.
Researchers have identified two oncogenes that drive the development of medulloblastoma brain cancer.
New research reveals two common gene variants which lead to longer telomeres also significantly increase the risk of developing gliomas.
A new synthetic peptide has the potential to deliver medications through the blood brain barrier.
Researchers report they have been able to create tiny, biodegradable nanoparticles which are able to carry DNA to brain cancer cells in mice.
Researchers find aspirin intake correlates with halted growth of vestibular schwannomas.
A genetic mutation associated with a number of cancers could also be responsible for papillary craniopharyngioma, a rare but debilitating brain tumor, a new study reports.
Researchers demonstrate melanoma differentiation associated gene, mda-9/syntenin is a driving force behind the aggressive and invasive nature of glioblastoma brain cancer.
Recurrent gliomas could have genetic profiles which are different from those of the initial tumors that spawned them, a new study reports.
A new study could pave the way for more effective treatment of infantile ETMR/ETANTR brain cancer.
Researchers discover the mTOR pathway is highly active in many cases of pediatric low-grade glioma. Blocking the pathway lead to a decreased growth of the brain tumors.
A novel therapeutic, which is based on nanotechnology, turns off a critical gene and increases survival rates in mice with glioblastoma brain cancer, a new study reports.
